BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6282231)

  • 1. [Serum concentration of C3 in primary lung cancer patients].
    Bariffi F; Marsico SA; Vigorito C; Alfani G; Donato Di Paola RM
    Arch Monaldi; 1980; 35(4):169-74. PubMed ID: 6282231
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunoglobulins and complement components levels in patients with lung cancer.
    Gmiński J; Mykała-Cieśla J; Machalski M; Drózdz M; Najda J
    Rom J Intern Med; 1992; 30(1):39-44. PubMed ID: 1323139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Carcinoembryonic antigen (CEA) in the blood serum of patients with primary bronchial cancer].
    Kozielski J; Seweryn J
    Pol Tyg Lek; 1985 Jan; 40(1):5-8. PubMed ID: 2983292
    [No Abstract]   [Full Text] [Related]  

  • 4. [Activated cells in the peripheral blood in lung cancer].
    Qian L
    Zhonghua Jie He He Hu Xi Za Zhi; 1988 Feb; 11(1):18-21, 62. PubMed ID: 2848634
    [No Abstract]   [Full Text] [Related]  

  • 5. [CEA distribution in BALF of lung cancer patients].
    Xu WB
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1988 Oct; 10(5):371-3. PubMed ID: 2855411
    [No Abstract]   [Full Text] [Related]  

  • 6. [Phagocytic activity in various lung tumors].
    Mikhova Ts; Uzunov P; Vlasov V; Vodenicharova S
    Eksp Med Morfol; 1988; 27(3):39-43. PubMed ID: 2851435
    [No Abstract]   [Full Text] [Related]  

  • 7. [The skin tests in operability evaluation of patients with non-small cell cancer of the lungs].
    Biondo FG; Caldarelli L; Bergaminelli C; Perillo G
    Arch Monaldi Mal Torace; 1988; 43(3):265-70. PubMed ID: 2855917
    [No Abstract]   [Full Text] [Related]  

  • 8. [Relation between serum carcinoembryonic antigen (CEA) level and microscopic features of lung cancer].
    Ochnio J; Szymańska D; Kwiek S; Rogińska E; Rowińska-Zakrzewska E
    Pneumonol Pol; 1984 Jul; 52(7):331-9. PubMed ID: 6093067
    [No Abstract]   [Full Text] [Related]  

  • 9. [Serum levels of CEA and ferritin in lung cancer before, during and after radiotherapy].
    Tatsuno I; Konishi K
    Rinsho Hoshasen; 1983 Nov; 28(12):1487-90. PubMed ID: 6323796
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical significance of serum SCC Ag in patients with squamous cell carcinoma of the lung].
    Zeng L
    Zhonghua Wai Ke Za Zhi; 1993 Mar; 31(3):143-5. PubMed ID: 8223022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunological status in small cell and squamous cell lung cancer].
    Janicka G; Przylipiak M; Chyczewska E; Kowal E
    Pol Tyg Lek; 1983 Aug; 38(32):985-8. PubMed ID: 6320142
    [No Abstract]   [Full Text] [Related]  

  • 12. [Significance of CEA in sputum in examination of lung cancer].
    Muraoka H; Katoh H; Moriya H; Kimura K; Higuchi Y
    Rinsho Hoshasen; 1985 Mar; 30(3):379-84. PubMed ID: 2991629
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical studies of idiopathic interstitial pneumonia associated with lung cancer].
    Kohno N; Takami S; Kamitsuna A; Ohnari K; Yamakido M; Nishimoto Y; Tsukiyama F
    Nihon Naika Gakkai Zasshi; 1983 Dec; 72(12):1731-9. PubMed ID: 6327859
    [No Abstract]   [Full Text] [Related]  

  • 14. Carcinoembryonic antigen fraction in lung cancer.
    Fong S; Leon V; Betancourt M; Guarnaluse R
    Neoplasma; 1983; 30(4):449-55. PubMed ID: 6310423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative evaluation of lymphocyte subpopulations, delayed cutaneous hypersensitivity reactions and autoantibody formation in cancer patients.
    Pichler WJ; Stingl G; Wagner G; Micksche M; Neumann H; Knapp W
    Osterr Z Onkol; 1977 Nov; 4(5-6):110-7. PubMed ID: 202907
    [No Abstract]   [Full Text] [Related]  

  • 16. [Humoral leukocyte adherence inhibition test in lung cancer].
    Wei HM
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1985 Feb; 8(1):25-7, 61. PubMed ID: 2986918
    [No Abstract]   [Full Text] [Related]  

  • 17. [Immunogenic activity of the regional lymphoreticulum during primary cancer of the lung].
    Lenzini L; Barnabé R
    Folia Allergol (Roma); 1969; 16(6):524-34. PubMed ID: 5401365
    [No Abstract]   [Full Text] [Related]  

  • 18. [Immunological aspects of lung cancer].
    Miquel Muse I; Klempert H; Mazzara R; Rodrĩguez Villamil J; Allo G; Korc I
    Torax; 1970 Dec; 19(4):222-31. PubMed ID: 5520152
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immunologic status in lung cancer].
    Briusov PG; Polovoĭ AM
    Sov Med; 1983; (3):16-9. PubMed ID: 6857368
    [No Abstract]   [Full Text] [Related]  

  • 20. Lung carcinoma: analysis of T helper type 1 and 2 cells and T cytotoxic type 1 and 2 cells by intracellular cytokine detection with flow cytometry.
    Ito N; Nakamura H; Tanaka Y; Ohgi S
    Cancer; 1999 Jun; 85(11):2359-67. PubMed ID: 10357406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.